Table of Content

1 Opioids Market Overview
1.1 Product Overview and Scope of Opioids
1.2 Opioids Segment by Type
1.2.1 Global Opioids Market Value Comparison by Type (2024-2034)
1.2.2 Oxycodone
1.2.3 Hydromorphone
1.2.4 Codeine
1.2.5 Fentanyl
1.2.6 Other
1.3 Opioids Segment by Application
1.3.1 Global Opioids Market Value by Application: (2024-2034)
1.3.2 Pain Relief
1.3.3 Anesthesia
1.3.4 Cough Suppression
1.3.5 Diarrhea Suppression
1.3.6 Deaddiction
1.3.7 Others
1.4 Global Opioids Market Size Estimates and Forecasts
1.4.1 Global Opioids Revenue 2018-2034
1.4.2 Global Opioids Sales 2018-2034
1.4.3 Global Opioids Market Average Price (2018-2034)
1.5 Assumptions and Limitations
2 Opioids Market Competition by Manufacturers
2.1 Global Opioids Sales Market Share by Manufacturers (2018-2023)
2.2 Global Opioids Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Opioids Average Price by Manufacturers (2018-2023)
2.4 Global Opioids Industry Ranking 2021 VS 2024 VS 2023
2.5 Global Key Manufacturers of Opioids, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Opioids, Product Type & Application
2.7 Opioids Market Competitive Situation and Trends
2.7.1 Opioids Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Opioids Players Market Share by Revenue
2.7.3 Global Opioids Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Opioids Retrospective Market Scenario by Region
3.1 Global Opioids Market Size by Region: 2018 Versus 2024 Versus 2034
3.2 Global Opioids Global Opioids Sales by Region: 2018-2034
3.2.1 Global Opioids Sales by Region: 2018-2023
3.2.2 Global Opioids Sales by Region: 2024-2034
3.3 Global Opioids Global Opioids Revenue by Region: 2018-2034
3.3.1 Global Opioids Revenue by Region: 2018-2023
3.3.2 Global Opioids Revenue by Region: 2024-2034
3.4 North America Opioids Market Facts & Figures by Country
3.4.1 North America Opioids Market Size by Country: 2018 VS 2024 VS 2034
3.4.2 North America Opioids Sales by Country (2018-2034)
3.4.3 North America Opioids Revenue by Country (2018-2034)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Opioids Market Facts & Figures by Country
3.5.1 Europe Opioids Market Size by Country: 2018 VS 2024 VS 2034
3.5.2 Europe Opioids Sales by Country (2018-2034)
3.5.3 Europe Opioids Revenue by Country (2018-2034)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Opioids Market Facts & Figures by Country
3.6.1 Asia Pacific Opioids Market Size by Country: 2018 VS 2024 VS 2034
3.6.2 Asia Pacific Opioids Sales by Country (2018-2034)
3.6.3 Asia Pacific Opioids Revenue by Country (2018-2034)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Opioids Market Facts & Figures by Country
3.7.1 Latin America Opioids Market Size by Country: 2018 VS 2024 VS 2034
3.7.2 Latin America Opioids Sales by Country (2018-2034)
3.7.3 Latin America Opioids Revenue by Country (2018-2034)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Opioids Market Facts & Figures by Country
3.8.1 Middle East and Africa Opioids Market Size by Country: 2018 VS 2024 VS 2034
3.8.2 Middle East and Africa Opioids Sales by Country (2018-2034)
3.8.3 Middle East and Africa Opioids Revenue by Country (2018-2034)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Opioids Sales by Type (2018-2034)
4.1.1 Global Opioids Sales by Type (2018-2023)
4.1.2 Global Opioids Sales by Type (2024-2034)
4.1.3 Global Opioids Sales Market Share by Type (2018-2034)
4.2 Global Opioids Revenue by Type (2018-2034)
4.2.1 Global Opioids Revenue by Type (2018-2023)
4.2.2 Global Opioids Revenue by Type (2024-2034)
4.2.3 Global Opioids Revenue Market Share by Type (2018-2034)
4.3 Global Opioids Price by Type (2018-2034)
5 Segment by Application
5.1 Global Opioids Sales by Application (2018-2034)
5.1.1 Global Opioids Sales by Application (2018-2023)
5.1.2 Global Opioids Sales by Application (2024-2034)
5.1.3 Global Opioids Sales Market Share by Application (2018-2034)
5.2 Global Opioids Revenue by Application (2018-2034)
5.2.1 Global Opioids Revenue by Application (2018-2023)
5.2.2 Global Opioids Revenue by Application (2024-2034)
5.2.3 Global Opioids Revenue Market Share by Application (2018-2034)
5.3 Global Opioids Price by Application (2018-2034)
6 Key Companies Profiled
6.1 Teva
6.1.1 Teva Corporation Information
6.1.2 Teva Description and Business Overview
6.1.3 Teva Opioids Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Teva Opioids Product Portfolio
6.1.5 Teva Recent Developments/Updates
6.2 Purdue Pharma
6.2.1 Purdue Pharma Corporation Information
6.2.2 Purdue Pharma Description and Business Overview
6.2.3 Purdue Pharma Opioids Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Purdue Pharma Opioids Product Portfolio
6.2.5 Purdue Pharma Recent Developments/Updates
6.3 Mallinckrodt
6.3.1 Mallinckrodt Corporation Information
6.3.2 Mallinckrodt Description and Business Overview
6.3.3 Mallinckrodt Opioids Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Mallinckrodt Opioids Product Portfolio
6.3.5 Mallinckrodt Recent Developments/Updates
6.4 Amneal Pharma
6.4.1 Amneal Pharma Corporation Information
6.4.2 Amneal Pharma Description and Business Overview
6.4.3 Amneal Pharma Opioids Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Amneal Pharma Opioids Product Portfolio
6.4.5 Amneal Pharma Recent Developments/Updates
6.5 Collegium
6.5.1 Collegium Corporation Information
6.5.2 Collegium Description and Business Overview
6.5.3 Collegium Opioids Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Collegium Opioids Product Portfolio
6.5.5 Collegium Recent Developments/Updates
6.6 J&J
6.6.1 J&J Corporation Information
6.6.2 J&J Description and Business Overview
6.6.3 J&J Opioids Sales, Revenue and Gross Margin (2018-2023)
6.6.4 J&J Opioids Product Portfolio
6.6.5 J&J Recent Developments/Updates
6.7 Endo
6.6.1 Endo Corporation Information
6.6.2 Endo Description and Business Overview
6.6.3 Endo Opioids Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Endo Opioids Product Portfolio
6.7.5 Endo Recent Developments/Updates
6.8 Pfizer
6.8.1 Pfizer Corporation Information
6.8.2 Pfizer Description and Business Overview
6.8.3 Pfizer Opioids Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Pfizer Opioids Product Portfolio
6.8.5 Pfizer Recent Developments/Updates
6.9 INSYS
6.9.1 INSYS Corporation Information
6.9.2 INSYS Description and Business Overview
6.9.3 INSYS Opioids Sales, Revenue and Gross Margin (2018-2023)
6.9.4 INSYS Opioids Product Portfolio
6.9.5 INSYS Recent Developments/Updates
6.10 Mylan
6.10.1 Mylan Corporation Information
6.10.2 Mylan Description and Business Overview
6.10.3 Mylan Opioids Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Mylan Opioids Product Portfolio
6.10.5 Mylan Recent Developments/Updates
6.11 Hikma
6.11.1 Hikma Corporation Information
6.11.2 Hikma Opioids Description and Business Overview
6.11.3 Hikma Opioids Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Hikma Opioids Product Portfolio
6.11.5 Hikma Recent Developments/Updates
6.12 Egalet
6.12.1 Egalet Corporation Information
6.12.2 Egalet Opioids Description and Business Overview
6.12.3 Egalet Opioids Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Egalet Opioids Product Portfolio
6.12.5 Egalet Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Opioids Industry Chain Analysis
7.2 Opioids Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Opioids Production Mode & Process
7.4 Opioids Sales and Marketing
7.4.1 Opioids Sales Channels
7.4.2 Opioids Distributors
7.5 Opioids Customers
8 Opioids Market Dynamics
8.1 Opioids Industry Trends
8.2 Opioids Market Drivers
8.3 Opioids Market Challenges
8.4 Opioids Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Opioids Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Opioids Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Opioids Market Competitive Situation by Manufacturers in 2024
Table 4. Global Opioids Sales (MT) of Key Manufacturers (2018-2023)
Table 5. Global Opioids Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Opioids Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Opioids Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Opioids Average Price (USD/Kg) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Opioids, Industry Ranking, 2021 VS 2024 VS 2023
Table 10. Global Key Manufacturers of Opioids, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Opioids, Product Type & Application
Table 12. Global Key Manufacturers of Opioids, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Opioids by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Opioids as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Opioids Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Table 17. Global Opioids Sales by Region (2018-2023) & (MT)
Table 18. Global Opioids Sales Market Share by Region (2018-2023)
Table 19. Global Opioids Sales by Region (2024-2034) & (MT)
Table 20. Global Opioids Sales Market Share by Region (2024-2034)
Table 21. Global Opioids Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Opioids Revenue Market Share by Region (2018-2023)
Table 23. Global Opioids Revenue by Region (2024-2034) & (US$ Million)
Table 24. Global Opioids Revenue Market Share by Region (2024-2034)
Table 25. North America Opioids Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 26. North America Opioids Sales by Country (2018-2023) & (MT)
Table 27. North America Opioids Sales by Country (2024-2034) & (MT)
Table 28. North America Opioids Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Opioids Revenue by Country (2024-2034) & (US$ Million)
Table 30. Europe Opioids Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 31. Europe Opioids Sales by Country (2018-2023) & (MT)
Table 32. Europe Opioids Sales by Country (2024-2034) & (MT)
Table 33. Europe Opioids Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Opioids Revenue by Country (2024-2034) & (US$ Million)
Table 35. Asia Pacific Opioids Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 36. Asia Pacific Opioids Sales by Region (2018-2023) & (MT)
Table 37. Asia Pacific Opioids Sales by Region (2024-2034) & (MT)
Table 38. Asia Pacific Opioids Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Opioids Revenue by Region (2024-2034) & (US$ Million)
Table 40. Latin America Opioids Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 41. Latin America Opioids Sales by Country (2018-2023) & (MT)
Table 42. Latin America Opioids Sales by Country (2024-2034) & (MT)
Table 43. Latin America Opioids Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Opioids Revenue by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa Opioids Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 46. Middle East & Africa Opioids Sales by Country (2018-2023) & (MT)
Table 47. Middle East & Africa Opioids Sales by Country (2024-2034) & (MT)
Table 48. Middle East & Africa Opioids Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Opioids Revenue by Country (2024-2034) & (US$ Million)
Table 50. Global Opioids Sales (MT) by Type (2018-2023)
Table 51. Global Opioids Sales (MT) by Type (2024-2034)
Table 52. Global Opioids Sales Market Share by Type (2018-2023)
Table 53. Global Opioids Sales Market Share by Type (2024-2034)
Table 54. Global Opioids Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Opioids Revenue (US$ Million) by Type (2024-2034)
Table 56. Global Opioids Revenue Market Share by Type (2018-2023)
Table 57. Global Opioids Revenue Market Share by Type (2024-2034)
Table 58. Global Opioids Price (USD/Kg) by Type (2018-2023)
Table 59. Global Opioids Price (USD/Kg) by Type (2024-2034)
Table 60. Global Opioids Sales (MT) by Application (2018-2023)
Table 61. Global Opioids Sales (MT) by Application (2024-2034)
Table 62. Global Opioids Sales Market Share by Application (2018-2023)
Table 63. Global Opioids Sales Market Share by Application (2024-2034)
Table 64. Global Opioids Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Opioids Revenue (US$ Million) by Application (2024-2034)
Table 66. Global Opioids Revenue Market Share by Application (2018-2023)
Table 67. Global Opioids Revenue Market Share by Application (2024-2034)
Table 68. Global Opioids Price (USD/Kg) by Application (2018-2023)
Table 69. Global Opioids Price (USD/Kg) by Application (2024-2034)
Table 70. Teva Corporation Information
Table 71. Teva Description and Business Overview
Table 72. Teva Opioids Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 73. Teva Opioids Product
Table 74. Teva Recent Developments/Updates
Table 75. Purdue Pharma Corporation Information
Table 76. Purdue Pharma Description and Business Overview
Table 77. Purdue Pharma Opioids Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 78. Purdue Pharma Opioids Product
Table 79. Purdue Pharma Recent Developments/Updates
Table 80. Mallinckrodt Corporation Information
Table 81. Mallinckrodt Description and Business Overview
Table 82. Mallinckrodt Opioids Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 83. Mallinckrodt Opioids Product
Table 84. Mallinckrodt Recent Developments/Updates
Table 85. Amneal Pharma Corporation Information
Table 86. Amneal Pharma Description and Business Overview
Table 87. Amneal Pharma Opioids Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 88. Amneal Pharma Opioids Product
Table 89. Amneal Pharma Recent Developments/Updates
Table 90. Collegium Corporation Information
Table 91. Collegium Description and Business Overview
Table 92. Collegium Opioids Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 93. Collegium Opioids Product
Table 94. Collegium Recent Developments/Updates
Table 95. J&J Corporation Information
Table 96. J&J Description and Business Overview
Table 97. J&J Opioids Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 98. J&J Opioids Product
Table 99. J&J Recent Developments/Updates
Table 100. Endo Corporation Information
Table 101. Endo Description and Business Overview
Table 102. Endo Opioids Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 103. Endo Opioids Product
Table 104. Endo Recent Developments/Updates
Table 105. Pfizer Corporation Information
Table 106. Pfizer Description and Business Overview
Table 107. Pfizer Opioids Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 108. Pfizer Opioids Product
Table 109. Pfizer Recent Developments/Updates
Table 110. INSYS Corporation Information
Table 111. INSYS Description and Business Overview
Table 112. INSYS Opioids Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 113. INSYS Opioids Product
Table 114. INSYS Recent Developments/Updates
Table 115. Mylan Corporation Information
Table 116. Mylan Description and Business Overview
Table 117. Mylan Opioids Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 118. Mylan Opioids Product
Table 119. Mylan Recent Developments/Updates
Table 120. Hikma Corporation Information
Table 121. Hikma Description and Business Overview
Table 122. Hikma Opioids Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 123. Hikma Opioids Product
Table 124. Hikma Recent Developments/Updates
Table 125. Egalet Corporation Information
Table 126. Egalet Description and Business Overview
Table 127. Egalet Opioids Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 128. Egalet Opioids Product
Table 129. Egalet Recent Developments/Updates
Table 130. Key Raw Materials Lists
Table 131. Raw Materials Key Suppliers Lists
Table 132. Opioids Distributors List
Table 133. Opioids Customers List
Table 134. Opioids Market Trends
Table 135. Opioids Market Drivers
Table 136. Opioids Market Challenges
Table 137. Opioids Market Restraints
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Opioids
Figure 2. Global Opioids Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Opioids Market Share by Type in 2024 & 2034
Figure 4. Oxycodone Product Picture
Figure 5. Hydromorphone Product Picture
Figure 6. Codeine Product Picture
Figure 7. Fentanyl Product Picture
Figure 8. Other Product Picture
Figure 9. Global Opioids Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 10. Global Opioids Market Share by Application in 2024 & 2034
Figure 11. Pain Relief
Figure 12. Anesthesia
Figure 13. Cough Suppression
Figure 14. Diarrhea Suppression
Figure 15. Deaddiction
Figure 16. Others
Figure 17. Global Opioids Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 18. Global Opioids Market Size (2018-2034) & (US$ Million)
Figure 19. Global Opioids Sales (2018-2034) & (MT)
Figure 20. Global Opioids Average Price (USD/Kg) & (2018-2034)
Figure 21. Opioids Report Years Considered
Figure 22. Opioids Sales Share by Manufacturers in 2024
Figure 23. Global Opioids Revenue Share by Manufacturers in 2024
Figure 24. The Global 5 and 10 Largest Opioids Players: Market Share by Revenue in 2024
Figure 25. Opioids Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2024
Figure 26. Global Opioids Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Figure 27. North America Opioids Sales Market Share by Country (2018-2034)
Figure 28. North America Opioids Revenue Market Share by Country (2018-2034)
Figure 29. U.S. Opioids Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 30. Canada Opioids Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 31. Europe Opioids Sales Market Share by Country (2018-2034)
Figure 32. Europe Opioids Revenue Market Share by Country (2018-2034)
Figure 33. Germany Opioids Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 34. France Opioids Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 35. U.K. Opioids Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 36. Italy Opioids Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 37. Russia Opioids Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 38. Asia Pacific Opioids Sales Market Share by Region (2018-2034)
Figure 39. Asia Pacific Opioids Revenue Market Share by Region (2018-2034)
Figure 40. China Opioids Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 41. Japan Opioids Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 42. South Korea Opioids Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 43. India Opioids Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 44. Australia Opioids Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 45. Taiwan Opioids Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 46. Indonesia Opioids Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 47. Thailand Opioids Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 48. Malaysia Opioids Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 49. Philippines Opioids Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 50. Latin America Opioids Sales Market Share by Country (2018-2034)
Figure 51. Latin America Opioids Revenue Market Share by Country (2018-2034)
Figure 52. Mexico Opioids Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 53. Brazil Opioids Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 54. Argentina Opioids Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 55. Middle East & Africa Opioids Sales Market Share by Country (2018-2034)
Figure 56. Middle East & Africa Opioids Revenue Market Share by Country (2018-2034)
Figure 57. Turkey Opioids Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 58. Saudi Arabia Opioids Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 59. U.A.E Opioids Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 60. Global Sales Market Share of Opioids by Type (2018-2034)
Figure 61. Global Revenue Market Share of Opioids by Type (2018-2034)
Figure 62. Global Opioids Price (USD/Kg) by Type (2018-2034)
Figure 63. Global Sales Market Share of Opioids by Application (2018-2034)
Figure 64. Global Revenue Market Share of Opioids by Application (2018-2034)
Figure 65. Global Opioids Price (USD/Kg) by Application (2018-2034)
Figure 66. Opioids Value Chain
Figure 67. Opioids Production Process
Figure 68. Channels of Distribution (Direct Vs Distribution)
Figure 69. Distributors Profiles
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed